A Dark Vector Cognition product

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

40K characters. Original on sec.gov ·

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The 21 tables in Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Table of Contents

Management's Discussion and Analysis

This report should be read in conjunction with our 2024 Form 10-K where we include additional information on our business, operating segments, risk factors, critical accounting estimates, policies, and the methods and assumptions used in our estimates, among other important information.

In the first quarter of 2025, we made an organizational change to integrate NEX into CCG and DCAI and modified our segment reporting to align to this and certain other business reorganizations. All prior period segment data has been retrospectively adjusted to reflect the way our CODM internally receives information and manages and monitors our operating segment performance starting in fiscal year 2025. There are no changes to our consolidated financial statements for any prior periods. "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements of this Form 10-Q provides additional information about our operating segments, including the nature of segment revenues and expenses, and reconciles our segment revenues presented below to our total consolidated net revenues and our segment operating income (loss) presented below to our total consolidated operating income (loss) for each of the periods presented.

Operating Segments Trends and Results

Intel Products

Intel Products consists substantially of the design, development, marketing, sale, support, and servicing of CPUs and related solutions for third-party customers. The manufacturing of our Intel Products' offerings is performed by Intel Foundry and, to a lesser extent, certain third party manufacturers. Intel Products is comprised of two operating segments: CCG and DCAI. CCG delivers platforms and processors that power personal computers, enabling enhanced performance, connectivity and user experiences. DCAI provides high-performance computing, AI acceleration, and infrastructure solutions, supporting data centers, cloud providers, and enterprises in meeting the growing demand for data processing and AI workloads.

Intel Products Financial Performance1

Q1 2025
($ in Millions)CCGDCAITotal
Revenue$7,629$4,126$11,755
Cost of sales3,9842,3596,343
Operating expenses1,2841,1922,476
Operating income$2,361$575$2,936
Operating margin %31%14%25%
Q1 2024
($ in Millions)CCGDCAITotal
Revenue$8,273$3,828$12,101
Cost of sales4,0041,7455,749
Operating expenses1,4471,6663,113
Operating income$2,822$417$3,239
Operating margin %34%11%27%

1 Operating segment results include intersegment financial activity; refer to "Note 2: Operating Segments" for a reconciliation between our operating segment and consolidated financial results for the periods presented.

Operating Segment Revenue Summary
Q1 2025 vs. Q1 2024

Total Intel Products revenue was $11.8 billion in Q1 2025, down $346 million from Q1 2024.

**▪**CCG revenue decreased $644 million from Q1 2024. Client revenue (collectively notebook and desktop) was $6.5 billion in Q1 2025, down $599 million from Q1 2024, primarily due to lower Q1 2025 client volume resulting from incremental customer incentives offered to certain customers in Q1 2024. Client ASPs in Q1 2025 were roughly flat with Q1 2024. Other CCG revenue was $1.1 billion, down $45 million from Q1 2024.

**▪**DCAI revenue increased $298 million from Q1 2024, primarily due to an increase in Q1 2025 product revenue from higher edge processing unit demand and higher Q1 2025 server revenue, primarily due to higher hyperscale customer-related demand which contributed to an increase in server volume of 16% and a decrease in server ASPs of 10% from Q1 2024.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A25

Table of Contents

Operating Segment Cost of Sales and Operating Expenses Summary
Q1 2025 vs. Q1 2024

Cost of Sales

Total Intel Products cost of sales was $6.3 billion in Q1 2025, up $594 million from Q1 2024.

**▪**CCG cost of sales decreased $20 million from Q1 2024, primarily driven by lower client sales volume in Q1 2025, substantially offset by higher period charges driven by lower sell-through of previously reserved inventory in Q1 2025.

**▪**DCAI cost of sales increased $614 million from Q1 2024, primarily driven by higher period charges as a result of Gaudi AI accelerator inventory reserves taken in Q1 2025, higher server unit costs from an increased mix of Intel 7 and Intel 3 products sold in Q1 2025 and higher server sales volume in Q1 2025.

Operating Expenses

Total Intel Products operating expenses were $2.5 billion, down $637 million from Q1 2024, primarily driven by lower payroll related expenditures resulting from headcount reductions taken under the 2024 Restructuring Plan and the effects of various other cost-reduction measures.

**▪**CCG operating expenses decreased $163 million from Q1 2024.

**▪**DCAI operating expenses decreased $474 million from Q1 2024.

Intel Foundry

Intel Foundry, comprising technology development, manufacturing and foundry services, seeks to deliver the best systems foundry capabilities to support Intel Products and external customers. As the stewards of Moore's Law, we aim to continue to innovate and advance world-class silicon process and advanced packaging technologies. We are strengthening the resilience of the global semiconductor supply chain for leading-edge and mature node semiconductor products by investing in geographically balanced and more sustainable manufacturing capacity.

Intel Foundry Financial Performance1

($ in Millions)Q1 2025Q1 2024
Revenue$4,667$4,356
Cost of sales5,9465,617
Operating expenses1,0411,180
Operating loss$(2,320)$(2,441)
Operating loss %(50)%(56)%

1 Operating segment results include intersegment financial activity; refer to "Note 2: Operating Segments" for a reconciliation between our operating segment and consolidated financial results for the periods presented.

Operating Segment Revenue Summary
Q1 2025 vs. Q1 2024

Revenue was $4.7 billion in Q1 2025, up $311 million from Q1 2024. Intersegment revenue was $4.6 billion, up $293 million from Q1 2024, primarily driven by higher back-end services and higher wafer volume from our Intel 3 and Intel 4 leading edge process nodes. External revenue was $31 million, up $18 million from Q1 2024.

Operating Segment Cost of Sales and Operating Expenses Summary
Q1 2025 vs. Q1 2024

Cost of Sales

Cost of sales was $5.9 billion in Q1 2025, up $329 million from Q1 2024, primarily driven by higher intersegment cost of goods sold from ramping advanced technologies, higher sales volume, and higher period charges primarily related to intersegment inventory reserves taken in Q1 2025.

Operating Expenses

Operating expenses were $1.0 billion in Q1 2025, down $139 million from Q1 2024, primarily driven by lower payroll related expenditures resulting from headcount reductions taken under the 2024 Restructuring Plan and the effects of various other cost-reduction measures.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A26

Table of Contents

All Other

Our "all other" category includes the results of operations from other non-reportable segments not otherwise presented, including our Altera and Mobileye businesses, our IMS business, start-up businesses that support our initiatives, and historical results of operations from divested businesses. Altera offers programmable semiconductors, primarily FPGAs, and related products, for a broad range of applications across our embedded, communications, cloud, enterprise, and defense and aerospace market segments. On April 14, 2025, we signed a transaction agreement with SLP VII Gryphon Aggregator, L.P., an affiliate of Silver Lake Partners, to sell 51% of all issued and outstanding common stock of Altera. The transaction is expected to close in the second half of 2025. Mobileye is a global leader in driving assistance and self-driving solutions, with a product portfolio designed to encompass the entire stack required for assisted and autonomous driving, including compute platforms, computer vision, and machine learning-based perception, mapping and localization, driving policy, and active sensors in development. IMS specializes in developing and manufacturing multi-beam mask writing tools.

All Other Financial Performance1

($ in Millions)Q1 2025Q1 2024
Revenue$943$643
Cost of sales396341
Operating expenses444472
Operating income (loss)$103$(170)
Operating margin (loss) %11%(26)%

1 Operating segment results include intersegment financial activity; refer to "Note 2: Operating Segments" for a reconciliation between our operating segment and consolidated financial results for the periods presented.

Operating Segments Revenue Summary
Q1 2025 vs. Q1 2024

All other revenue was $943 million, up $300 million from Q1 2024. Mobileye revenue was $438 million, up $199 million from Q1 2024 as customer inventory levels improved compared to higher levels in Q1 2024. Altera revenue was $368 million, up $26 million from Q1 2024.

Operating Segments Cost of Sales and Operating Expenses Summary
Q1 2025 vs. Q1 2024

Cost of Sales

Total all other cost of sales was $396 million, up $55 million from Q1 2024, primarily driven by higher Q1 2025 Mobileye revenue.

Operating Expenses

All other operating expenses were $444 million, down $28 million from Q1 2024.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A27

Table of Contents

Consolidated Condensed Results of Operations
Q1 2025Q1 2024
(In Millions, Except Per Share Amounts)Amount% of Net RevenueAmount% of Net Revenue
Net revenue$12,667100.0%$12,724100.0%
Cost of sales7,99563.1%7,50759.0%
Gross margin4,67236.9%5,21741.0%
Research and development3,64028.7%4,38234.4%
Marketing, general, and administrative1,1779.3%1,55612.2%
Restructuring and other charges1561.2%3482.7%
Operating income (loss)(301)(2.4)%(1,069)(8.4)%
Gains (losses) on equity investments, net(112)(0.9)%2051.6%
Interest and other, net(173)(1.4)%1451.1%
Income (loss) before taxes(586)(4.6)%(719)(5.7)%
Provision for (benefit from) taxes3012.4%(282)(2.2)%
Net income (loss)(887)(7.0)%(437)(3.4)%
Less: net income (loss) attributable to non-controlling interests(66)(0.5)%(56)(0.4)%
Net income (loss) attributable to Intel$(821)(6.5)%$(381)(3.0)%
Earnings (loss) per share attributable to Intel—diluted$(0.19)$(0.09)
intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A28

Table of Contents

Consolidated Revenue

Consolidated Revenue Walk $B1

27

Q1 2025 vs. Q1 2024

Our Q1 2025 revenue was $12.7 billion, roughly flat with Q1 2024. Intel Products revenue decreased 3% primarily due to lower CCG revenue, partially offset by higher DCAI revenue. CCG revenue decreased 8% from Q1 2024, primarily due to lower client revenue driven by lower Q1 2025 client volumes that were primarily attributable to the absence of incremental purchasing incentives offered to certain customers in Q1 2024. DCAI revenue increased 8% from Q1 2024, primarily driven by an increase in product revenue from higher edge processing unit demand and higher server revenue, primarily due to higher hyperscale customer-related demand. All other revenue increased 47% from Q1 2024, primarily driven by higher Mobileye revenue, as customer inventory levels improved compared to higher levels in Q1 2024.

Incentives offered to certain customers to accelerate purchases and to strategically position our products with customers for market segment share purposes, particularly in CCG, contributed approximately $1.6 billion to our revenue during Q1 2024. These incentives were insignificant in Q1 2025.

1 Excludes intersegment revenue; totals may not sum due to rounding.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A29

Table of Contents

Consolidated Gross Margin

We derived a majority of our consolidated gross margin in Q1 2025 and Q1 2024 from our Intel Products business sales through our CCG and DCAI operating segments.

Gross Margin $B
(Percentages in chart indicate gross margin as a percentage of total revenue)

7146825582673

Q1 2025 vs. Q1 2024

Our consolidated gross margin in Q1 2025 decreased by $545 million, or 10%, compared to Q1 2024, primarily driven by higher period charges as a result of Gaudi AI accelerator inventory reserves taken in Q1 2025.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A30

Table of Contents

Consolidated R&D and MG&A Expenses

Total R&D and MG&A expenses for Q1 2025 were $4.8 billion, down 19% from Q1 2024. These expenses represent 38.0% of revenue for Q1 2025 and 46.7% of revenue for Q1 2024. In support of our strategy, described in our 2024 Form 10-K, we continue to make significant investments to accelerate our process technology roadmap. As a result of our 2024 Restructuring Plan and related cost-reduction measures, we expect a decrease in total R&D and MG&A expenses in 2025 relative to recent historical periods as we focus investments in R&D and create capacity for sustained investment in technology and manufacturing.

Research and Development $BMarketing, General, and Administrative $B

(Percentages in chart indicate operating expenses as a percentage of total revenue)

701

715

Research and Development

Q1 2025 vs. Q1 2024

R&D decreased by $742 million, or 17%, compared to Q1 2024 primarily driven by lower payroll-related expenditures resulting from headcount reductions taken under the 2024 Restructuring Plan, as well as the effects of various other cost-reduction measures and lower share-based compensation.
Marketing, General, and Administrative

Q1 2025 vs. Q1 2024

MG&A decreased by $379 million, or 24%, compared to Q1 2024 primarily driven by lower payroll-related expenditures resulting from headcount reductions taken under the 2024 Restructuring Plan, as well as the effects of various other cost-reduction measures and lower share-based compensation.
intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A31

Table of Contents

Restructuring and Other Charges

(In Millions)Q1 2025Q1 2024
Employee severance and benefit arrangements$142$129
Litigation charges and other11—
Asset impairment charges3219
Total restructuring and other charges$156$348

In Q3 2024, the 2024 Restructuring Plan was announced, subsequently approved and committed to by our management team, and initiated to implement cost-reduction measures, including reductions in employee headcount, other operating expenditures, and capital expenditures (see "Note 6: Restructuring and Other Charges" within Notes to Consolidated Condensed Financial Statements). We expect to amend our 2024 Restructuring Plan in Q2 2025 for additional actions that we expect to take. We expect that our 2024 Restructuring Plan, in conjunction with other initiatives, will reduce our cost structure while we continue our investments to develop, manufacture, market, sell, and deliver product and process initiatives in furtherance of our strategy. We expect actions pursuant to the 2024 Restructuring Plan to be substantially complete by the fourth quarter of 2025, which is subject to change. Any changes to the estimates or timing will be reflected in our results of operations.

Employee severance and benefit arrangements includes charges relating to the 2024 Restructuring Plan of $142 million in Q1 2025. The charges in Q1 2024 related to other actions taken to streamline operations and to reduce costs.

Asset impairment charges includes a non-cash goodwill impairment related to our Intel Foundry reporting unit of $222 million in Q1 2024. Refer to "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements for further information.

Gains (Losses) on Equity Investments and Interest and Other, Net

(In Millions)Q1 2025Q1 2024
Unrealized gains (losses) on marketable equity investments$(292)$253
Unrealized gains (losses) on non-marketable equity investments1—24
Impairment charges(105)(69)
Unrealized gains (losses) on equity investments, net(397)208
Realized gains (losses) on sales of equity investments, net285(3)
Gains (losses) on equity investments, net$(112)$205
Interest and other, net$(173)$145

1 Unrealized gains (losses) on non-marketable investments includes observable price adjustments and our share of equity method investee gains (losses) and certain distributions.

In Q1 2025, mark-to-market losses for marketable equity investments were primarily driven by share price declines related to our investment in Montage, which were offset by open market sales during the quarter.

In Q1 2024, gains (losses) on equity investments, net were primarily driven by a $410 million mark-to-market gain related to our interest in Astera Labs, Inc.

Provision for (Benefit from) Taxes

($ In Millions)Q1 2025Q1 2024
Income (loss) before taxes$(586)$(719)
Provision for (benefit from) taxes$301$(282)
Effective tax rate(51.4)%39.2%

In Q1 2025, our provision for income taxes was determined using our estimated annual effective tax rate, adjusted for discrete items, applied to our year-to-date measure of ordinary income (loss) before taxes, which reflects our jurisdictional mix of ordinary income and losses, including the valuation allowance applied to U.S. deferred tax balances.

In Q1 2024, our benefit from income taxes was determined using an actual annual effective tax rate, adjusted for discrete items, as we were unable to make a reliable estimate of our annual effective tax rate as a result of fluctuations in forecasted annual income and the effects of being taxed in multiple tax jurisdictions.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A32

Table of Contents

Liquidity and Capital Resources

We consider the following when assessing our liquidity and capital resources:

(In Millions)Mar 29, 2025Dec 28, 2024
Cash and cash equivalents$8,947$8,249
Short-term investments12,10113,813
Total cash and short-term investments$21,048$22,062
Total debt$50,151$50,011

We believe we have sufficient sources of funding to meet our business requirements for the next 12 months and in the longer term. Cash generated by operations, and total cash and short-term investments as shown in the preceding table, are our primary sources of liquidity for funding our strategic business requirements. These sources are further supplemented by our committed credit facilities and other borrowing capacity and certain other Smart Capital initiatives that we have undertaken. Our short-term funding requirements include capital expenditures for worldwide manufacturing and assembly and test, including investments in our process technology roadmap; investments in our product roadmap; working capital requirements; partner distributions to our non-controlling interest holders; and strategic investments. Our long-term funding requirements incrementally contemplate investments in significant manufacturing expansion plans and investments to accelerate our process technology. These plans include expanding existing operations in Arizona, New Mexico, and Oregon, and investing in a new leading-edge manufacturing facility in Ohio. They may also include longer-term projects, certain of which we have currently put on hold or slowed the completion of, including a new leading-edge manufacturing facility, a new assembly and test facility, and a new advanced packaging facility, among others.

In November 2024, we signed a Direct Funding Agreement with the US Department of Commerce for the award of $7.9 billion in government incentives pursuant to the CHIPS Act, from which we received $1.1 billion of cash in Q1 2025. We expect to continue to benefit from government incentives, though recent US government actions create uncertainty regarding timing of the US government fulfilling its obligation under our CHIPS Act agreements, and supporting future awards in the US. These government incentives typically require that we make significant capital investments in new facilities or expand existing facilities, and our related workforce. To the extent we delay or cancel any such projects or otherwise are unable or fail to comply with the terms of the agreements, there may be a delay in our receipt of, or we may forfeit or be required to repay, the associated government incentives.

In Q1 2025, we closed the second phase of our NAND memory business divestiture and received $1.9 billion of cash proceeds, net of certain adjustments. See "Note 9: Divestitures" within Notes to Consolidated Condensed Financial Statements for further information.

Our total cash and short-term investments and related cash flows may be affected by certain discretionary actions we may take with customers and suppliers to accelerate or delay certain cash receipts or payments to manage liquidity, among other factors, for our strategic business requirements. These actions can include, among others, negotiating with suppliers to optimize our payment terms and conditions, adjusting the amounts and timing of cash flows associated with customer sales programs and collections, managing inventory levels and purchasing practices, and selling certain of our accounts receivables on a non-recourse basis to third-party financial institutions. While such actions have benefited, and may further benefit, cash flow in the near term, we may experience a corresponding detriment to cash flow in future periods as these actions cease or as the impacts of these actions reverse or normalize.

In Q1 2025, we amended our 364-day $8.0 billion credit facility agreement to $5.0 billion and the maturity date was extended by one year to January 2026. Additionally, we have access to our $7.0 billion revolving credit facility, which remains available until February 2029. We have other potential sources of liquidity including our commercial paper program and our automatic shelf registration statement on file with the SEC, pursuant to which we may offer an unspecified amount of debt, equity, and other securities. Under our commercial paper program, we have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion. As of March 29, 2025, we had $1.5 billion of commercial paper obligations outstanding and no outstanding borrowings on the revolving credit facilities. See "Note 10: Borrowings" within Notes to Consolidated Condensed Financial Statements for further information. As part of our ongoing capital management strategy to optimize our debt portfolio and reduce interest expense, we may utilize make-whole provisions, tender offers or open market repurchases to repurchase our debt prior to maturity. In Q1 2025 and Q1 2024, we did not extinguish any debt prior to maturity.

We maintain a diverse investment portfolio that we continually analyze based on issuer, industry, and country. Substantially all of our investments in debt instruments were in investment-grade securities.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A33

Table of Contents

Cash flows from operating, investing, and financing activities were as follows:

Three Months Ended
(In Millions)Mar 29, 2025Mar 30, 2024
Net cash provided by (used for) operating activities$813$(1,223)
Net cash provided by (used for) investing activities81(2,563)
Net cash provided by (used for) financing activities(196)3,630
Net increase (decrease) in cash and cash equivalents$698$(156)

Operating Activities

Operating cash flows consist of net income (loss) adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash was provided by operations in the first three months of 2025 compared to cash used for operations in the first three months of 2024 and was primarily due to more favorable changes in working capital as well as higher favorable operating cash flow adjustments for non-cash items, which were offset by lower net income in the first three months of 2025 compared to the first three months of 2024.

Investing Activities

Investing cash flows consist primarily of capital expenditures; investment purchases, sales, maturities, and disposals; proceeds from divestitures; and proceeds from capital-related government incentives.

Cash was provided by investing activities in the first three months of 2025 compared to cash used for investing activities in the first three months of 2024 and was primarily due to lower purchases of short-term investments, proceeds from the divestiture of our NAND memory business, and other cash favorable investing activity in the first three months of 2025. These cash favorable movements were partially offset by lower maturities and sales of short-term investments in the first three months of 2025 compared to the first three months of 2024.

Financing Activities

Financing cash flows consist primarily of proceeds from strategic initiatives including partner contributions and equity-related issuances, issuance and repayment of short-term and long-term debt, and financing for capital expenditures with extended payment terms.

Cash was used for financing activities in the first three months of 2025 compared to cash provided by financing activities in the first three months of 2024 and was primarily due to a net cash decrease in debt-related proceeds, higher capital expenditures with extended payment terms, higher debt repayments, and other cash unfavorable financing activity in the first three months of 2025. These cash unfavorable movements were partially offset by increased partner contributions and no dividend payments in the first three months of 2025 compared to the first three months of 2024.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgMD&A34

Table of Contents

Risk Factors and Other Key Information

Previous: Item 1. Financial Statements · Next: Item 1A. Risk Factors